封面
市场调查报告书
商品编码
1577009

压力治疗市场、机会、成长动力、产业趋势分析与预测,2024-2032

Compression Therapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 262 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球压力治疗市场价值约为34 亿美元,预计2024 年至2032 年复合年增长率为5.5%。的病症。市场的显着成长主要是由于糖尿病和肥胖症发病率的上升、产品技术的进步以及慢性静脉疾病和淋巴水肿的盛行率不断增加。

整个产业分为产品、技术、应用、配销通路、区域

加压治疗市场依产品分为加压服、加压背带、加压带和加压帮浦。 2023年,压缩衣细分市场以约17亿美元的收入引领市场。压力衣可治疗多种疾病,包括静脉曲张、淋巴水肿、慢性静脉闭塞、深部静脉栓塞 (DVT) 和术后恢復。它们广泛的适用性使它们成为医疗保健提供者和患者的首选。

从应用来看,静脉曲张治疗领域占据了大部分市场份额,2023 年收入约为 13 亿美元。压力疗法通常是静脉曲张的首选非侵入性或微创治疗选择,涉及使用压力袜或压力绷带来改善血液循环并减轻症状,使其受到患者和医疗保健提供者的欢迎。

2023年北美压力治疗市场价值11亿美元,预计2024-2032年将大幅成长。该地区静脉疾病、糖尿病、肥胖和心血管疾病等疾病的流行往往需要加压疗法作为其治疗的一部分,从而推动了市场的成长。此外,该地区人口老化,容易出现静脉功能不全和淋巴水肿等疾病,可以从压力疗法中受益。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 运动伤害和事故数量增加
      • 骨科手术数量增加
      • 大量未解决的患者群体
      • 患者对治疗选择的认识不断提高
      • 最近的技术进步
    • 产业陷阱与挑战
      • 替代治疗的可用性
      • 由于佩戴者不适而降低依从性
      • 使用压力疗法的副作用
  • 成长潜力分析
  • 技术景观
  • 未来市场趋势
  • 监管环境
    • 我们
    • 欧洲
    • 亚太地区
  • 报销场景
  • 差距分析
  • 启动场景
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2021 - 2032 年

  • 主要趋势
  • 压缩衣
    • 加压绷带
    • 压力袜
      • 压缩等级 I
      • 压缩等级 II
      • 压缩等级 III
    • 其他压缩衣
  • 压缩支架
  • 压缩带
  • 压缩帮浦

第 6 章:市场估计与预测:按技术划分,2021 - 2032 年

  • 主要趋势
  • 静态加压疗法
  • 动态加压疗法

第 7 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 静脉曲张治疗
  • 深部静脉血栓治疗
  • 淋巴水肿治疗
  • 腿部溃疡治疗
  • 其他应用

第 8 章:市场估计与预测:按配销通路,2021 - 2032 年

  • 主要趋势
  • 医院药房
  • 零售药局
  • 网路药局

第 9 章:市场估计与预测:按地区划分,2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • 3M Company
  • Alcare Company Ltd.
  • ArjoHuntleigh
  • BIO Compression Systems, Inc.
  • Cardinal Health, Inc.
  • ConvaTec Inc.
  • DJO Global Inc.
  • Essity AB
  • Julius Zorn GmbH
  • Medi GmbH and Co. KG
  • PAUL HARTMANN AG
  • Sanyleg SRL
  • Sigvaris AG
  • Smith and Nephew Plc.
  • Tactile Medical
简介目录
Product Code: 2504

The Global Compression Therapy Market was valued at approximately USD 3.4 billion in 2023 and is projected to grow at 5.5% CAGR from 2024 to 2032. Compression therapy enhances circulation and manages conditions related to blood flow and swelling in the extremities, particularly the legs and arms. The significant market growth is primarily due to the rising incidence of diabetes and obesity, technological advancements in products, and the increasing prevalence of chronic venous disorders and lymphedema.

The overall industry is divided into product, technology, application, distribution channel, and region

The compression therapy market is segmented by product into compression garments, compression braces, compression tapes, and compression pumps. In 2023, the compression garments segment led the market with a revenue of around USD 1.7 billion. Compression garments treat various conditions, including varicose veins, lymphedema, chronic venous occlusions, deep vein thrombosis (DVT), and post-surgical recovery. Their broad applicability makes them a preferred choice among healthcare providers and patients.

By application, the varicose vein treatment segment held the majority market share, with revenue of around USD 1.3 billion in 2023. Varicose veins, drive the demand for effective treatment options. Compression therapy, often a preferred non-invasive or minimally invasive treatment option for varicose veins, involves using compression stockings or wraps to improve circulation and reduce symptoms, making it popular among patients and healthcare providers.

North America compression therapy market was valued at USD 1.1 billion in 2023 and is expected to witness substantial growth during 2024-2032. The prevalence of conditions, such as venous disorders, diabetes, obesity, and cardiovascular diseases in the region often necessitates compression therapy as part of their management, driving market growth. Additionally, the aging population in the region, prone to conditions, such as venous insufficiency and lymphedema, benefits from compression therapy.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in number of sports injuries and accidents
      • 3.2.1.2 Rise in number of orthopedic procedures
      • 3.2.1.3 Large unaddressed patient population
      • 3.2.1.4 Growing awareness among the patients regarding treatment options
      • 3.2.1.5 Recent technological advancements
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Availability of alternative treatments
      • 3.2.2.2 Reduced compliance due to wearer discomfort
      • 3.2.2.3 Side-effects with the use of compression therapy
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Future market trends
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
  • 3.7 Reimbursement scenario
  • 3.8 Gap analysis
  • 3.9 Start-up scenario
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Compression garments
    • 5.2.1 Compression bandages
    • 5.2.2 Compression stockings
      • 5.2.2.1 Compression class I
      • 5.2.2.2 Compression class II
      • 5.2.2.3 Compression class III
    • 5.2.3 Other compression garments
  • 5.3 Compression braces
  • 5.4 Compression tapes
  • 5.5 Compression pumps

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Static compression therapy
  • 6.3 Dynamic compression therapy

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Varicose vein treatment
  • 7.3 Deep vein thrombosis treatment
  • 7.4 Lymphedema treatment
  • 7.5 Leg ulcer treatment
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospital pharmacies
  • 8.3 Retail pharmacies
  • 8.4 Online pharmacies

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 3M Company
  • 10.2 Alcare Company Ltd.
  • 10.3 ArjoHuntleigh
  • 10.4 BIO Compression Systems, Inc.
  • 10.5 Cardinal Health, Inc.
  • 10.6 ConvaTec Inc.
  • 10.7 DJO Global Inc.
  • 10.8 Essity AB
  • 10.9 Julius Zorn GmbH
  • 10.10 Medi GmbH and Co. KG
  • 10.11 PAUL HARTMANN AG
  • 10.12 Sanyleg S.R.L
  • 10.13 Sigvaris AG
  • 10.14 Smith and Nephew Plc.
  • 10.15 Tactile Medical